Serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 do not correlate with Gleason score or quantity of prostate cancer in biopsy samples.

Ismail, H A; Pollak, M; Behlouli, H; Tanguay, S; Bégin, L R; Aprikian, A G

Ismail, H A; Pollak, M; Behlouli, H; Tanguay, S; Bégin, L R; Aprikian, A G.

Affiliation

Ismail HA; Department of Surgery, McGill University, and the Montreal General Hospital Research Institute, Montreal, Quebec, Canada.

BJU Int ; 92(7): 699-702, 2003 Nov.

Article in En | MEDLINE | ID: mdl-14616449

Subject(s)

Biomarkers, Tumor/blood; Insulin-Like Growth Factor Binding Protein 3/blood; Insulin-Like Growth Factor I/analysis; Neoplasm Proteins/blood; Prostate/pathology; Prostatic Neoplasms/blood; Aged; Biopsy/methods; Biopsy/standards; Humans; Male; Prostatic Neoplasms/pathology; Sensitivity and Specificity; Ultrasonography, Interventional

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms / Insulin-Like Growth Factor I / Biomarkers, Tumor / Insulin-Like Growth Factor Binding Protein 3 / Neoplasm Proteins Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2003 Document type: Article Affiliation country: Canada

Search on Google

Add to My VHL

XML

PubMed Links